HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

diabeton

Also Known As:

Benzoic acid, 2-amino-5-hydroxy-

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Antonova, K V: 1 article (02/2007)
2.	Arzamastseva, N E: 1 article (02/2007)
3.	Balabolkin, M I: 1 article (02/2007)
4.	Konovalova, G G: 1 article (02/2007)
5.	Lankin, V Z: 1 article (02/2007)
6.	Nedosugova, L V: 1 article (02/2007)
7.	Reznik, S M: 1 article (02/2007)

Related Diseases

1.	Hyperglycemia 01/01/2023 - "The aim of this study was to evaluate i) the involvement of microvascular disorders and neuronal plasticity in the deleterious effects of a high-fructose diet on the rat brain and ii) a comparative assessment of the effectiveness of Phytocollection therapy (with antidiabetic, antioxidant, and acetylcholinesterase inhibitory activities) compared to Galantamine as first-line therapy for dementia and Diabeton as first-line therapy for hyperglycemia. "
2.	Dementia (Dementias) 01/01/2023 - "The aim of this study was to evaluate i) the involvement of microvascular disorders and neuronal plasticity in the deleterious effects of a high-fructose diet on the rat brain and ii) a comparative assessment of the effectiveness of Phytocollection therapy (with antidiabetic, antioxidant, and acetylcholinesterase inhibitory activities) compared to Galantamine as first-line therapy for dementia and Diabeton as first-line therapy for hyperglycemia. "
3.	Type 2 Diabetes Mellitus (MODY) 01/01/1991 - "[The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus]." 02/15/2007 - "The impact of glycemic control on the parameters of free radical oxidation was comparatively studied in patients with type 2 diabetes who received metformin (Glucophage, Nycomed) (Group 1, n = 40) and sulfanylurea preparations (Group 2, n - 30, out of them 15 patients took maninil and 15 had diabeton) good glycemic control caused the magnitude of oxidative stress to reduce, which appeared as the decreased levels of primary (lipid hydroperoxides) and secondary (malonic dialdehyde) products of free radical oxidation in LDL and as the enhanced activity of antioxidative defense enzymes. "
4.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/01/1991 - "[Diabeton in the treatment of stage I nephroangiopathy in insulin-dependent diabetes mellitus]."
5.	Diabetes Mellitus 08/01/1986 - "[Use of diabeton in patients with initial forms of diabetes mellitus]."

Related Drugs and Biologics

1.	Hypoglycemic Agents (Hypoglycemics)
2.	Galantamine (Galanthamine)
3.	Fructose
4.	Antioxidants
5.	Acetylcholinesterase
6.	Metformin (Glucophage)
7.	Free Radicals
8.	Phospholipids (Phosphatides)
9.	Lipids
10.	Glyburide (Glibenclamide)

Related Therapies and Procedures

1.	Therapeutics
2.	Glycemic Control